Myopathy damages the muscular system by weakening and breaking down individual muscle fibers, reducing their ability to contract with normal force. The result is progressive muscle weakness that typically starts in the large muscles closest to the trunk of your body, like the shoulders, hips, and thighs. Depending on the type of myopathy, this damage can come from genetic defects in muscle proteins, immune system attacks on muscle tissue, energy production failures inside muscle cells, or even medications.
Which Muscles Are Affected First
The most common pattern in myopathy is symmetric proximal weakness, meaning it affects muscles on both sides of the body and targets those closest to your center. The hip flexors, quadriceps, shoulder muscles, and upper arms are usually hit earliest. This is why people with myopathy often notice trouble climbing stairs, getting up from a chair, or lifting their arms overhead before they notice any weakness in their hands or feet.
Some forms break this pattern. Inclusion body myositis, for example, targets the quadriceps and the muscles that flex your fingers, creating a distinctive combination of weak grip and difficulty walking. Facioscapulohumeral muscular dystrophy weakens facial muscles along with those supporting the shoulder blade and upper arm. But in the majority of myopathies, whether inherited, inflammatory, or drug-related, the proximal muscles bear the brunt first.
How Muscle Fibers Break Down
Healthy muscle fibers contain organized bundles of proteins that slide past each other to produce contraction. Myopathy disrupts this system at the fiber level in several ways. In some inherited forms, mutations prevent the contractile proteins from assembling into the thick filaments that power movement. Lab studies have shown that certain mutations reduce the speed of muscle contraction by several fold, even when the muscle fiber is still structurally intact. Other mutations cause misfolded proteins to accumulate inside the fiber, forming clumps that interfere with normal function and eventually trigger fiber death.
As damaged fibers die, the body attempts to regenerate them using stem cells embedded in the muscle (called satellite cells). In many myopathies, this repair process fails to keep pace with destruction. A signaling molecule called TGF-beta, released during muscle injury, can actually redirect those stem cells away from forming new muscle and toward producing scar tissue instead. Over time, functional muscle fibers are progressively replaced by fat and fibrous connective tissue. Muscle biopsies from patients with advanced Duchenne muscular dystrophy show dramatically fewer muscle fibers, with most of the tissue replaced by this fatty-fibrous infiltrate.
Inflammatory Myopathies: The Immune System Attacks Muscle
In inflammatory myopathies like dermatomyositis and polymyositis, the immune system itself causes the damage, though through different routes. In dermatomyositis, the immune system targets the tiny blood vessels that supply muscle fibers. Immune proteins called complement attack the walls of capillaries, destroying them and cutting off blood flow. The resulting oxygen deprivation injures and kills muscle fibers, particularly those at the edges of muscle bundles where blood supply is most vulnerable.
Polymyositis works differently. Immune cells (specifically a type of white blood cell called CD8+ T cells) directly invade individual muscle fibers. These T cells contain perforin, a protein that punches holes in the muscle fiber’s membrane, allowing destructive enzymes and calcium to flood in and kill the cell. Microscopy studies have confirmed that these immune cells orient their toxic granules directly toward muscle fibers, consistent with a targeted killing mechanism. The overall prevalence of inflammatory myopathies is roughly 32 per 100,000 people, with antisynthetase syndrome and dermatomyositis among the most common subtypes.
When Energy Production Fails
Mitochondrial myopathies take a different approach to disabling muscle. Rather than destroying the structural proteins or triggering immune attacks, these conditions impair the mitochondria, the parts of each cell responsible for converting nutrients into usable energy (ATP). Skeletal muscle has one of the highest energy demands of any tissue in the body, making it especially vulnerable when this energy production system falters.
The hallmark symptom is exercise intolerance. Your muscles may feel adequate at rest but fatigue rapidly with even mild exertion because they simply cannot produce ATP fast enough to sustain contraction. Walking distance drops. Activities that were once easy become exhausting. Unlike the structural myopathies where fibers are physically destroyed, mitochondrial myopathies create a chronic energy crisis that limits what intact muscle fibers can do.
Drug-Induced Muscle Damage
Statins, the widely prescribed cholesterol-lowering drugs, cause muscle symptoms in up to 30% of people who take them. These symptoms range from muscle pain and tenderness to measurable weakness. Statins work by blocking an enzyme called HMG-CoA reductase, and this same pathway appears to affect muscle cell health through mechanisms still being clarified. In rare cases, statins can trigger an autoimmune response where the body produces antibodies against the enzyme itself. These antibodies target the surface of muscle fibers and activate complement (the same destructive immune cascade seen in dermatomyositis), causing ongoing muscle injury that can persist even after the statin is stopped.
Other medications can cause myopathy as well. Long-term corticosteroid use causes a chronic myopathy affecting proximal muscles, often accompanied by the rounded facial features and weight redistribution of Cushing’s syndrome. Antimalarial drugs like hydroxychloroquine can damage limb muscles and, in some cases, the heart muscle.
How Myopathy Is Detected in Muscle
When muscle fibers are damaged, they leak an enzyme called creatine phosphokinase (CPK) into the bloodstream. Normal CPK levels run between 10 and 120 micrograms per liter. Elevated levels signal that muscle tissue is actively breaking down, though the degree of elevation varies widely between myopathy types.
A more specific test is electromyography (EMG), which measures the electrical activity of muscle fibers. In healthy muscle, each nerve signal activates a group of fibers that produce a coordinated electrical burst. In myopathy, many fibers within each group are damaged or dead, so the electrical signals become smaller and shorter than normal. The remaining healthy fibers fire out of sync with each other, creating irregular, “polyphasic” patterns. To compensate for weak individual motor units, the nervous system recruits many more motor units than it normally would for a given movement. This rapid recruitment pattern is a telltale sign that distinguishes myopathic weakness from nerve-related weakness.
Exercise and Muscle Preservation
Exercise in myopathy once seemed counterintuitive, since asking damaged muscles to work harder could theoretically accelerate their destruction. Research has consistently shown the opposite. Studies across all types and stages of inflammatory myopathy have found exercise to be safe, and it is now considered a core part of treatment. The current recommendation is to start at low intensity under the guidance of a physical therapist, then gradually increase over time.
For building strength, the target is 60 to 80 percent of your maximum capacity, two to three times per week. For endurance, a lighter load of 30 to 40 percent at the same frequency. Home exercise programs at low to moderate intensity, tailored to individual disease activity and disability level, have been well studied in patients with recent-onset disease and are well tolerated. The key is regular progression: as your disease activity changes and your physical capacity shifts, the program should be adjusted to match.